Transcript

Webb spots outsized early black hole & GSK hepatitis B drug boosts cures - News (May 29, 2026)

May 29, 2026

Back to episode

Picture a newborn galaxy in the early Universe where the black hole isn’t just big—it’s practically the whole story, making up most of the system’s mass. That’s what astronomers say they’ve now measured with the James Webb Space Telescope. Welcome to The Automated Daily, top news edition. The podcast created by generative AI. I’m TrendTeller, and today is May 29th, 2026. Here are the stories shaping the day—across space, health, climate, and global security.

We’ll start in deep space, because this one is hard to ignore. Astronomers using the James Webb Space Telescope say they’ve mapped gas swirling around a supermassive black hole in a tiny early galaxy known as Abell2744-QSO1—seen as it was roughly 700 million years after the Big Bang. The striking part: they estimate the black hole weighs about 50 million Suns and accounts for roughly two-thirds of the entire system’s mass. In today’s Universe, black holes are massive, but they’re usually a small fraction of their host galaxy. Here, the black hole looks more like the main event than a side character—fueling a growing debate that some supermassive black holes may have formed first and helped assemble galaxies around them.

In medical news, a major hepatitis B update could change what “treatable” means for millions of people. New Phase 3 results for GSK’s experimental drug bepirovirsen show a “functional cure” in about one in five patients with chronic infection—around 20% in one large study and 19% in another—while nobody on placebo hit that endpoint. That’s notable because today’s standard antivirals typically deliver functional cures in only a small slice of patients. With chronic hepatitis B affecting hundreds of millions worldwide and contributing to liver cancer and cirrhosis, even a minority cure rate at this level would be a meaningful step up. GSK has submitted the therapy for review to regulators including the FDA, so the next key question is whether these results translate into an approved new option in clinics.

Another health headline: researchers at UC San Diego say a naturally occurring peptide called catestatin may help slow melanoma and, importantly, may help counter a common problem—tumors that stop responding to standard targeted treatments. In lab experiments and mouse models, catestatin reduced tumor growth and seemed to curb behaviors linked to spread, like migration and invasiveness. The researchers also report that the peptide dampened gene activity tied to survival and drug resistance, and appeared to affect melanoma cells more than normal skin cells. It’s early-stage work, not a ready-to-prescribe therapy, but it adds to a broader theme in cancer research: looking for smarter ways to push back when tumors adapt and treatment options narrow.

Staying with biomedical science, a team at the University of Cambridge has built connected human brain and spinal cord organoids—miniature tissue models—that can grow nerve fibers between them and even trigger contractions in nearby muscle-cell clusters. Their takeaway is both sobering and hopeful. They found that in younger, less mature neural circuits, damaged axons could regrow for a time, but that ability dropped sharply as the system matured—mirroring why adult brain and spinal cord injuries are so often permanent. The encouraging part: gene-activity signals pointed to a kind of developmental “off switch” that suppresses regrowth as neural connections mature. When the team blocked parts of that network, more mature neurons regained some ability to extend axons after injury, and a drug screen flagged an existing hormone medication, lynestrenol, as a candidate that boosted regrowth in this model. It’s not a cure for paralysis—but it is a clearer clue about what might be shutting human nerve repair down, and how that barrier might be nudged.

Now to climate, where the next few years look increasingly tough to ignore. A new World Meteorological Organization report, produced with the U.K. Met Office, projects that the period from 2026 to 2030 is highly likely to be the hottest five-year stretch on record. The report puts strong odds on repeated crossings of the 1.5°C warming mark relative to pre-industrial levels, and warns that even small additional temperature increases stack risks quickly—more punishing heat waves, heavier floods, harsher droughts, and larger wildfire seasons, along with knock-on effects like food price shocks. The outlook is reinforced by forecasts of a strong El Niño developing and potentially persisting for years, which could push at least one year—possibly 2027—into new record territory. The report also highlights the Arctic, warming far faster than the global average, and warns about hotter, drier conditions in parts of the Amazon that could raise fire risk and weaken the rainforest’s role as a carbon sink.

Turning to geopolitics and energy, a Foreign Affairs essay argues that after three months of war triggered by joint U.S.-Israeli attacks on Iran, the Trump administration is facing a painful problem: no clear off-ramp. The piece describes a standoff that has effectively shut the Strait of Hormuz to most shipping, removing a huge flow of Persian Gulf oil from global markets—roughly 14 million barrels per day, by the essay’s accounting. Despite heavy airstrikes, the authors say Iran’s government remains intact and defiant, raising doubts that further escalation will deliver decisive outcomes. They note that Pakistan is mediating diplomatic exchanges and that hints of a limited deal are emerging. The larger point is the obvious one: the longer the chokepoint stays squeezed, the more the economic pressure builds, and the harder it becomes to keep the conflict from widening.

On security and technology, the head of the U.K.’s signals intelligence agency, GCHQ, Anne Keast-Butler, is warning that artificial intelligence is becoming an “unstoppable force” in modern conflict—especially in the grey zone between peace and war. Speaking at Bletchley Park, she said allies are seeing daily hybrid operations that target critical infrastructure, democratic processes, supply chains, and public trust—often calibrated to stay below the threshold that would trigger a traditional military response. She highlighted concerns around undersea cables and energy pipelines, and cautioned that Western countries could fall behind in cyberspace without faster action from governments and industry. The message is less about sci-fi and more about scale: AI can help attackers move faster, test more options, and create confusion more cheaply—raising the risk of miscalculation at a moment she called among the most dangerous of her career.

And finally, an update from NATO’s eastern flank. Germany and the Netherlands say they will establish a joint tactical headquarters in the Baltic region this year, intended to help command forces and sharpen deterrence in the Estonia–Latvia area. The aim is added capacity and quicker decision-making, alongside existing NATO command structures, at a time when European officials have been increasingly concerned about sabotage risks and other hybrid threats across the region. In plain terms, this is about readiness and coordination—making it easier to move from planning and exercises to real-world command if the security situation deteriorates.

That’s the top news for May 29th, 2026. If one theme ties today together, it’s momentum—whether it’s a black hole that seems to have grown up too fast, a drug that could raise hepatitis B cure rates, or climate and security risks accelerating faster than the systems built to manage them. Thanks for listening to The Automated Daily, top news edition. I’m TrendTeller. Check back tomorrow for a fresh, fast run-through of what matters—and why.